dacarbazine has been researched along with Agranulocytosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 2 (28.57) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, HQ; Liu, ZF; Tao, RJ | 1 |
Avilés, A; Castañeda, C; Cleto, S; González, M; Huerta-Guzmán, J; Neri, N; Talavera, A | 1 |
Basso, U; Brandes, AA; Cavallo, G; Ermani, M; Ferreri, AJ; Monfardini, S; Panucci, MG; Reni, M; Scopece, L; Tosoni, A; Vastola, F | 1 |
Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD | 1 |
Bartolucci, A; Buchanan, R; Krauss, S; Lowenbraun, S; Perez, C; Sonoda, T | 1 |
Avilés, A; Díaz-Maqueo, JC; García, EL; Guzmán, R; Talavera, A | 1 |
Burgess, MA; Hersh, EM; Legha, SS; Papadopoulos, N; Plager, C; Verschraegen, CF | 1 |
6 trial(s) available for dacarbazine and Agranulocytosis
Article | Year |
---|---|
Treatment of advanced Hodgkin's disease: EBVD versus intensive brief chemotherapy.
Topics: Actuarial Analysis; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Infections; Male; Middle Aged; Survival Analysis; Treatment Outcome; Vinblastine | 2003 |
First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Drug Interactions; Female; Glioblastoma; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Temozolomide; Thrombocytopenia; Treatment Outcome | 2004 |
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Thrombocytopenia; Vinblastine; Vincristine | 1983 |
Combined modality treatment of localized small-cell lung carcinoma. A randomized prospective study of the Southeastern Cancer Study Group.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies | 1980 |
Randomized study for the treatment of adult advanced Hodgkin's disease: epirubicin, vinblastine, bleomycin, and dacarbazine (EVBD) versus mitoxantrone, vinblastine, bleomycin, and dacarbazine (MVBD).
Topics: Actuarial Analysis; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemical and Drug Induced Liver Injury; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Mitoxantrone; Prospective Studies; Thrombocytopenia; Treatment Outcome; Ventricular Function, Left; Vinblastine | 1994 |
Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanoma.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Dacarbazine; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Prognosis; Vindesine | 1993 |
1 other study(ies) available for dacarbazine and Agranulocytosis
Article | Year |
---|---|
[Protracted low-dose temozolomide combined with concomitant whole brain radiotherapy for brain metastases from non-small cell lung cancer].
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Temozolomide; Vomiting | 2011 |